top of page
Neuromagen Pharma
Develops novel drugs that enhance telomerase activity for neuroprotection, aiming to delay the onset and progression of ALS and other neurodegenerative diseases.
Company Name | Neurotech Category | Market Category | Company Founded Year | Company Location |
|---|---|---|---|---|
Neuromagen Pharma | NeuroPharmacology | NeuroBioTechnology | Biotechnology & Biopharmaceutical | 2021 | Be'er Sheva |
Develops novel drugs that enhance telomerase activity for neuroprotection, aiming to delay the onset and progression of ALS and other neurodegenerative diseases.
bottom of page